Editorial Board Editor-in-Chief: N. GeorgopapadakouVP Research, NovaBay Pharmaceuticals, Emeryville, CA, USA email: nafsikag@aol.com
Section Editor: Bacteria N. Georgopapadakou, VP Research, NovaBay Pharmaceuticals, Emeryville, CA, USA
Section Editor: Cancer H.J. Broxterman, Department of Medical Oncology, CCA 1-38, Free University Hospital, Amsterdam, The Netherlands
Section Editor: Fungi J.R. Perfect, Duke University, Durham, North Carolina, USA
Section Editor: Protozoa S.A. Ward, Pharmacology Research Laboratories, University of Liverpool, Liverpool, UK
Section Editor: Viruses E.J. Arts, Department of Medicine, Case Western Reserve University, Cleveland, Ohio, USA
Editorial Board G.L. Archer, USA Y.G. Assaraf, Israel F. Baquero, Spain W.T. Beck, USA P. Borst, The Netherlands C. Brancolini, Italy P.A. Bunn, USA C. Cass, Canada H.F. Chambers, USA D.M. Coen, USA P. Courvalin, France A. Cowman, Australia E. Cundliffe, UK E.D.A. DeClerq, Belgium P. Dennis, USA E.G.E. De Vries, The Netherlands R.E.W. Hancock, Canada F.G. Hayden, USA K. Hiramatsu, Japan D. Hooper, USA P.J. Houghton, USA G.A. Jacoby, USA P.J. Johnson, USA M.B. Kastan, USA S.B. Kaye, UK S.L. Kelly, UK J. Kovacs, USA B. Kreiswirth, USA D.R. Kuritzkes, USA S.A. Lerner, USA S. Levy, USA R. Moellering, USA J. Montaner, Canada P.J. Morin, USA B. Murray, USA H. Nikaido, USA M. Ouellette, Canada I. Peterson, USA Y.G. Pommier, USA L. Pusztai, USA J. Rex, UK D. Richman, USA I. Roninson, USA B. Rosen, USA M. Sande, USA D. Sanglard, Switzerland R.A. Skurray, Australia A. Sparreboom, USA B. Spratt, UK B.A. Teicher, USA K.D. Tew, USA M.A. Wainberg, Canada T. Walsh, USA D. Warnock, USA T. Wellems, USA N.J. White, Thailand B. Wiedemann, Germany C.R. Wolf, UK
|
